Literature DB >> 14017481

Triton hypercholesteremia: cause or consequence of augmented cholesterol synthesis.

S O BYERS, M FIEDMAN, T SUGIYAMA.   

Abstract

Entities:  

Keywords:  ACETATES; CHOLESTEROL; HYPERCHOLESTEREMIA; LIVER; SURFACE-ACTIVE AGENTS

Mesh：

Substances：

Year:  1963        PMID： 14017481     DOI： 10.1152/ajplegacy.1963.204.6.1100

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  7 in total

1.  Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.

Authors:  P E Schurr; J R Schultz; T M Parkinson
Journal:  Lipids       Date:  1972-01       Impact factor: 1.880

2.  The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions.

Authors:  S Otway; D S Robinson
Journal:  J Physiol       Date:  1967-05       Impact factor: 5.182

3.  Effects of Triton WR 1339 and orotic acid on lipid metabolism in rats.

Authors:  N Takeuchi; M Murase; Y Nomura; H Takase; K Uchida
Journal:  Lipids       Date:  1987-08       Impact factor: 1.880

4.  Reversal by triton WR-1339 of ethynyloestradiol-induced hepatic cholesterol esterification.

Authors:  R A Davis; R Showalter; F Kern
Journal:  Biochem J       Date:  1978-07-15       Impact factor: 3.857

5.  3-Hydroxy-3-methylglutaric acid and triton-induced hyperlipidemia in rats.

Authors:  S Y Yousufzai; M Siddiqi
Journal:  Experientia       Date:  1976-09-15

6.  Anti-obesity activity of chloroform-methanol extract of Premna integrifolia in mice fed with cafeteria diet.

Authors:  Prashant Y Mali; Papiya Bigoniya; Shital S Panchal; Irrappa S Muchhandi
Journal:  J Pharm Bioallied Sci       Date:  2013-07

7.  Antihypercholesterolemic and Antioxidative Potential of an Extract of the Plant, Piper betle, and Its Active Constituent, Eugenol, in Triton WR-1339-Induced Hypercholesterolemia in Experimental Rats.

Authors:  Karuppasamy Venkadeswaran; Arumugam Ramachandran Muralidharan; Thangaraj Annadurai; Vasanthakumar Vasantha Ruban; Mahalingam Sundararajan; Ramalingam Anandhi; Philip A Thomas; Pitchairaj Geraldine
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-09       Impact factor: 2.629
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.